5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 10.35▲ | 10.36 | 10.35▲ | 10.70▼ | 10.60▼ |
MA10 | 10.34▲ | 10.37▼ | 10.37▼ | 10.85▼ | 9.45▲ |
MA20 | 10.35▲ | 10.38▼ | 10.51▼ | 10.67▼ | 8.80▲ |
MA50 | 10.37▼ | 10.67▼ | 10.84▼ | 9.30▲ | 8.10▲ |
MA100 | 10.37▼ | 10.87▼ | 10.85▼ | 8.72▲ | 7.04▲ |
MA200 | 10.49▼ | 10.82▼ | 10.53▼ | 8.20▲ | 9.45▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.018▲ | 0.001▲ | -0.141▼ | 0.275▲ |
RSI | 50.619▲ | 40.199▼ | 32.545▼ | 50.743▲ | 64.297▲ |
STOCH | 55.068 | 56.186 | 51.576 | 40.888 | 86.223▲ |
WILL %R | -26.316 | -31.034 | -57.447 | -81.739▼ | -17.753▲ |
CCI | 24.936 | -25.521 | -66.077 | -178.650▼ | 81.411 |
Friday, June 13, 2025 04:11 AM
BioCryst Pharmaceuticals, Inc. announced that Colombia's National Institute of Drug and Food Surveillance (INVIMA) has approved ORLADEYO® (berotralstat), an oral medication for preventing ...
|
Friday, June 13, 2025 04:00 AM
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO® ...
|
Wednesday, June 11, 2025 10:53 AM
Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 10.21 | 10.46 | 10.16 | 10.37 | 2,661,229 |
12/06/25 | 10.55 | 10.64 | 10.34 | 10.40 | 3,813,742 |
11/06/25 | 11.06 | 11.07 | 10.59 | 10.61 | 3,267,646 |
10/06/25 | 11.065 | 11.215 | 10.985 | 11.015 | 1,751,320 |
09/06/25 | 11.20 | 11.23 | 10.97 | 11.11 | 3,423,985 |
06/06/25 | 11.06 | 11.18 | 10.88 | 11.04 | 4,093,558 |
05/06/25 | 11.01 | 11.105 | 10.90 | 10.98 | 3,568,835 |
04/06/25 | 11.23 | 11.31 | 10.995 | 11.04 | 3,955,508 |
03/06/25 | 10.65 | 11.24 | 10.51 | 11.19 | 4,162,407 |
02/06/25 | 10.79 | 11.15 | 10.69 | 10.73 | 3,988,356 |
|
|
||||
|
|
||||
|
|